Serial Number | 97235079 |
Word Mark | C THE S!GNS |
Filing Date | Monday, January 24, 2022 |
Status | 731 - SECOND EXTENSION - GRANTED |
Status Date | Monday, September 9, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, July 18, 2023 |
Goods and Services | (Based on 44(e)) Educational and training services relating to healthcare, namely, conducting training, workshops, classes in the field of healthcare; (Based on Intent To Use) education services, namely, conducting training, workshops, classes in the field of healthcare; providing of training in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients, rendered through correspondence courses; teaching in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; arranging and conducting of conferences, seminars and training workshops in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; providing education in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients rendered through correspondence courses; educational services, namely, conducting classes, workshops, seminars in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; vocational guidance; organisation of exhibitions for educational purposes; providing on-line electronic publications in the nature of books, magazines, brochures, leaflets in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; information, advisory and consultancy services relating to all of the aforesaid; all of the aforesaid services relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients and none of the aforesaid relating to the testing and screening of neurological conditions |
Description of Mark | The mark consists of a stylized letter "C" consisting of three curved lines with the stylized words "THE SIGNS" with the letter "I" as an exclamation mark. |
Goods and Services | (Based on 44(e)) Downloadable artificial intelligence software for healthcare for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; (Based on Intent To Use) downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; downloadable software applications for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; downloadable application software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; downloadable computer software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; downloadable smartphone software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; computer software platforms, recorded or downloadable for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; downloadable mobile application software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; digital media, namely, downloadable audio and audiovisual recordings featuring information and advice relating to cancer risk, cancer diagnosis, cancer treatment and the clinical needs of patients; multi-platform digital tools, namely, downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; all of the aforesaid goods for use in relation to and relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients and none of the aforesaid relating to the testing and screening of neurological conditions |
Pseudo Mark | C THE SIGNS |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Goods and Services | (Based on 44(e)) Data processing services in the field of healthcare; (Based on Intent To Use) data management, namely, database management, computer data entry services; data processing services; database management; computer data entry services and data processing services; compilation of data for business purposes; automated data processing services; electronic data collection services for business purposes in the fields of medicine and healthcare; systematization of data in computer databases; collating of data in computer databases, namely, compilation and systemization of information into computer databases; market research data analysis; online data processing services; preparation of healthcare statistical data, namely, providing statistical healthcare information for business or commercial purposes; dissemination of data relating to healthcare, namely, providing business information in the field of healthcare, database processing services; data and database improvement, namely, updating and maintenance of data in computer databases; data and database enhancement, namely, updating and maintenance of data in computer databases; combining data from multiple sources into databases, namely, systemization of data in computer databases; information, advisory and consultancy services relating to all of the aforesaid; all of the aforesaid services relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients and none of the aforesaid relating to the testing and screening of neurological conditions |
Goods and Services | (Based on 44(e)) Healthcare; medical services; hospital services and medical clinics; medical assistance; nursing services; health screening services in the field of cancer; medical information; health care services in the nature of dissemination of data relating to healthcare, namely, providing a database in the field of cancer information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; all of the aforesaid services relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; advisory and consultancy services relating to all of the aforesaid and none of the aforesaid relating to the testing and screening of neurological conditions |
Goods and Services | (Based on 44(e)) Information technology services for the pharmaceutical and healthcare industries, namely, providing information technology consulting services, and providing temporary use of online non-downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; (Based on Intent To Use) providing online, non-downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; software as a service (SaaS) services featuring software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; platform as a service (PaaS) services featuring computer software platforms for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing online, non-downloadable software platforms for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing online, non-downloadable software, software as a service (SaaS) services featuring software, platform as a service (PaaS) services featuring computer software platforms and online, non-downloadable software platforms all for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; information, advisory and consultancy services relating to all of the aforesaid; providing temporary use of online non-downloadable artificial intelligence software for healthcare for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non- downloadable software applications for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable application software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable computer software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable smartphone software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable mobile application software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; multi-platform digital tools, namely, providing temporary use of online non-downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; compilation of data, namely, compiling data for research purposes in the field of medical science and medical consultancy; database improvement, namely, maintenance of on-line databases for others; database enhancement, namely, maintenance of on-line databases for others; all of the aforesaid services relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients and none of the aforesaid relating to the testing and screening of neurological conditions |
International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
US Class Codes | 021, 023, 026, 036, 038 |
Class Status Code | 6 - Active |
Class Status Date | Friday, June 2, 2023 |
Primary Code | 009 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Friday, June 2, 2023 |
Primary Code | 035 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
US Class Codes | 100, 101, 107 |
Class Status Code | 6 - Active |
Class Status Date | Friday, June 2, 2023 |
Primary Code | 041 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, June 2, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, June 2, 2023 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | C the Signs Limited |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | London W1G9QD GB |
Party Name | C the Signs Limited |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | London W1G9QD GB |
Event Date | Event Description |
Thursday, January 27, 2022 | NEW APPLICATION ENTERED |
Thursday, January 27, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, January 28, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Wednesday, November 2, 2022 | ASSIGNED TO EXAMINER |
Monday, November 7, 2022 | TEAS VOLUNTARY AMENDMENT RECEIVED |
Tuesday, November 8, 2022 | NON-FINAL ACTION WRITTEN |
Tuesday, November 8, 2022 | NON-FINAL ACTION E-MAILED |
Tuesday, November 8, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, January 4, 2023 | ASSIGNED TO LIE |
Thursday, January 5, 2023 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
Wednesday, February 1, 2023 | NON-FINAL ACTION WRITTEN |
Wednesday, February 1, 2023 | NON-FINAL ACTION E-MAILED |
Wednesday, February 1, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, May 1, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, May 1, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, May 2, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, June 2, 2023 | EXAMINERS AMENDMENT -WRITTEN |
Friday, June 2, 2023 | EXAMINERS AMENDMENT E-MAILED |
Friday, June 2, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Friday, June 2, 2023 | EXAMINER'S AMENDMENT ENTERED |
Friday, June 2, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, June 14, 2023 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Tuesday, July 18, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Wednesday, June 28, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, July 18, 2023 | PUBLISHED FOR OPPOSITION |
Tuesday, September 12, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Monday, September 9, 2024 | SOU TEAS EXTENSION RECEIVED |
Monday, September 9, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, September 9, 2024 | SOU EXTENSION 2 GRANTED |
Monday, September 9, 2024 | SOU EXTENSION 2 FILED |
Wednesday, February 28, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, February 27, 2024 | SOU TEAS EXTENSION RECEIVED |
Tuesday, February 27, 2024 | SOU EXTENSION 1 FILED |
Tuesday, February 27, 2024 | SOU EXTENSION 1 GRANTED |